80_FR_82081 80 FR 81830 - Proposed Collection; 60 Day Comment Request; The Framingham Heart Study (NHLBI)

80 FR 81830 - Proposed Collection; 60 Day Comment Request; The Framingham Heart Study (NHLBI)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 251 (December 31, 2015)

Page Range81830-81832
FR Document2015-32940

In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Heart, Lung, and Blood Institute (NHLBI), the National Institutes of Health (NIH), will publish periodic summaries of proposed projects to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology.

Federal Register, Volume 80 Issue 251 (Thursday, December 31, 2015) 
[Federal Register Volume 80, Number 251 (Thursday, December 31, 2015)]
[Notices]
[Pages 81830-81832]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-32940]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60 Day Comment Request; The Framingham Heart 
Study (NHLBI)

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of 
the Paperwork Reduction Act of 1995, for opportunity for public comment 
on proposed data collection projects, the National Heart, Lung, and 
Blood Institute (NHLBI), the National Institutes of Health (NIH), will 
publish periodic summaries of proposed projects to the Office of 
Management and Budget (OMB) for review and approval.
    Written comments and/or suggestions from the public and affected 
agencies are invited on one or more of the following points: (1) 
Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have practical utility; (2) The accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
used; (3) Ways to enhance the quality, utility, and clarity of the 
information to be collected; and (4) Ways to minimize the burden of the 
collection of information on those who are to respond, including the 
use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments, submit comments in writing, or 
request more information on the proposed project, contact: Paul Sorlie, 
6701 Rockledge Drive, MSC 7936, Bethesda, MD 20892, or call non-toll-
free number (301) 435-0456, or Email your request to: 
sorliep@nhlbi.nih.gov. Formal requests for additional plans and 
instruments must be requested in writing.
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of the date of this publication.
    Proposed Collection: The Framingham Heart Study, Revision, 0925-
0216 Expiration Date: 10/31/2016, National Heart, Lung, and Blood 
Institute (NHLBI), the National Institutes of Health (NIH).
    Need and Use of Information Collection: This proposal is to extend 
the Framingham Study to examine the Generation Three Cohort, New 
Offspring Spouses and Omni Group 2 Cohort, as well as to continue to 
monitor the morbidity and mortality which occurs in all Framingham 
Cohorts. The contractor, with the collaborative assistance of NHLBI 
Intramural staff, will invite study participants, schedule 
appointments, administer examinations and testing, enter information 
into computer databases for editing, and prepare scientific reports of 
the information for publication in appropriate scientific journals. All

[[Page 81831]]

participants have been examined previously and thus the study deals 
with a stable, carefully described group. Data are collected in the 
form of an observational health examination involving such components 
as blood pressure measurements, venipuncture, electrocardiography and a 
health interview, including questions about lifestyles and daily living 
situations. The National Heart, Lung, and Blood Institute uses the 
results of the Framingham Study to: (1) Characterize risk factors for 
cardiovascular and lung diseases so that national prevention programs 
can be designed and implemented; (2) evaluate trends in cardiovascular 
diseases and risk factors over time to measure the impact of overall 
preventive measures; and (3) understand the etiology of cardiovascular 
and lung diseases so that effective treatment and preventive modalities 
can be developed and tested. Most of the reports of study results have 
been published in peer reviewed medical journals and books.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 8,382.

Estimated Annualized Burden Hours

                         Table A.12-1.1--Estimate of Respondent Burden, Original Cohort
                                                  [Annualized]
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
               Type of respondent                    Number of     responses per   per response    Total annual
                                                    respondents     respondent      (in hours)      burden hour
----------------------------------------------------------------------------------------------------------------
I. PARTICIPANT COMPONENTS
ANNUAL FOLLOW-UP
    a. Records Request..........................              30               1           15/60               8
    b. Health Status Update.....................              30               1           15/60               8
                                                 ---------------------------------------------------------------
        SUB-TOTAL: PARTICIPANT COMPONENTS.......            * 30  ..............  ..............              15
II. NON-PARTICIPANT COMPONENTS
    A. Informant Contact (Pre-exam and Annual                 15               1           10/60               3
     Follow-up).................................
    B. Records Request (Annual follow-up).......              30               1           15/60               8
                                                 ---------------------------------------------------------------
        SUB-TOTAL: NON-PARTICIPANT COMPONENTS...              45  ..............  ..............              10
                                                 ---------------------------------------------------------------
            TOTAL: PARTICIPANT AND NON-                       75  ..............  ..............              25
             PARTICIPANT COMPONENTS.............
----------------------------------------------------------------------------------------------------------------
* Number of participants as reflected in Row I.b. above.


             Table A.12-1.2--Estimate of Respondent Burden, Offspring Cohort and Omni Group 1 Cohort
                                                  [Annualized]
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
               Type of respondent                    Number of     responses per   per response    Total annual
                                                    respondents     respondent      (in hours)      burden hour
----------------------------------------------------------------------------------------------------------------
I. PARTICIPANT COMPONENTS
ANNUAL FOLLOW-UP
    a. Records Request..........................           1,500               1           15/60             375
    b. Health Status Update.....................           1,700               1           15/60             425
                                                 ---------------------------------------------------------------
        SUB-TOTAL: PARTICIPANT COMPONENTS.......         * 1,700  ..............  ..............             800
II. NON-PARTICIPANT COMPONENTS
    A. Informant contact (Pre-exam and Annual                150               1           10/60              25
     Follow-up).................................
    B. Records Request (Annual follow-up).......           1,500               1           15/60             375
                                                 ---------------------------------------------------------------
        SUB-TOTAL: NON-PARTICIPANT COMPONENTS...           1,650  ..............  ..............             400
                                                 ---------------------------------------------------------------
            TOTAL: PARTICIPANT AND NON-                    3,350  ..............  ..............           1,200
             PARTICIPANT COMPONENTS.............
----------------------------------------------------------------------------------------------------------------
* Number of participants as reflected in Row I.b. above.


         Table A.12-1.3--Estimate of Respondent Burden, Generation 3 Cohort, NOS and Omni Group 2 Cohort
                                                  [Annualized]
----------------------------------------------------------------------------------------------------------------
                                                                                   Average time
                                                     Number of       Number of     per response    Total annual
               Type of respondent                   respondents    responses per    (hours per      burden hour
                                                                    respondent         year)
----------------------------------------------------------------------------------------------------------------
                                            I. PARTICIPANT COMPONENTS
----------------------------------------------------------------------------------------------------------------
A. PRE-EXAM:
    1.Telephone contact for appointment.........           1,450               1           10/60             242
    2. Exam appointment, scheduling, reminder              1,270               1           35/60             741
     and instructions...........................
B. EXAM CYCLE 3:
    1. Exam at study center.....................           1,200               1          110/60           2,200

[[Page 81832]]

 
    2. Home or nursing home visit...............              35               1           60/60              35
C. POST-EXAM:
    eFHS Mobile Technology for Collection of CVD           1,100              18            9/60           2,970
     Risks......................................
D. ANNUAL FOLLOW-UP:
    1. Records Request..........................           1,200               1           15/60             300
    2. Health Status Update.....................           1,400               1           15/60             350
                                                 ---------------------------------------------------------------
        Sub-Total: Participant Components.......         * 2,850  ..............  ..............           6,830
----------------------------------------------------------------------------------------------------------------
                                II. NON-PARTICIPANT COMPONENTS--ANNUAL FOLLOW-UP
----------------------------------------------------------------------------------------------------------------
A. INFORMANT CONTACTS...........................             180               1           10/60              30
B. RECORD REQUEST...............................           1,155               1           15/60             289
                                                 ---------------------------------------------------------------
    Sub-Total: Non-Participant Components.......           1,335  ..............  ..............             319
                                                 ---------------------------------------------------------------
        Total: Participant And Non-Participant             4,185  ..............  ..............           7,157
         Components.............................
----------------------------------------------------------------------------------------------------------------
* Number of participants as reflected in Rows I.A.1 and I.D.2 above.


    Dated: December 22, 2015.
Valery Gheen,
NHLBI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2015-32940 Filed 12-30-15; 8:45 am]
BILLING CODE 4140-01-P

81830 Federal Register / Vol. 80, No. 251 / Thursday, December 31, 2015 / Notices I. Background it satisfies the requirements of the Institute (NHLBI), the National All medical devices have benefits and applicable statutes and regulations. Institutes of Health (NIH), will publish risks. Health care providers, patients, periodic summaries of proposed III. Electronic Access and consumers must weigh these projects to the Office of Management Persons interested in obtaining a copy and Budget (OMB) for review and benefits and risks when making health of the draft guidance may do so by approval. care decisions. FDA weighs probable downloading an electronic copy from Written comments and/or suggestions benefit to health from the use of the the Internet. A search capability for all from the public and affected agencies device against any probable risk of Center for Devices and Radiological are invited on one or more of the injury or illness from such use in Health guidance documents is available following points: (1) Whether the determining the safety and effectiveness at http://www.fda.gov/MedicalDevices/ proposed collection of information is of a device. However, not all DeviceRegulationandGuidance/ necessary for the proper performance of information regarding benefits and risks GuidanceDocuments/default.htm. the function of the agency, including for a given device may be fully known Guidance documents are also available whether the information will have or characterized prior to the device at http://www.regulations.gov. Persons practical utility; (2) The accuracy of the reaching the market. New information unable to download an electronic copy agency’s estimate of the burden of the about the safety and/or effectiveness of of ‘‘Public Notification of Emerging proposed collection of information, the device often becomes available once Postmarket Medical Device Signals including the validity of the the device is more widely distributed (‘Emerging Signals’)’’ may send an email methodology and assumptions used; (3) and used under real-world conditions of request to CDRH-Guidance@fda.hhs.gov Ways to enhance the quality, utility, and actual clinical practice. to receive an electronic copy of the clarity of the information to be FDA is issuing this draft guidance to document. Please use the document collected; and (4) Ways to minimize the describe the Agency’s policy for number 1500027 to identify the burden of the collection of information notifying the public about medical guidance you are requesting. on those who are to respond, including device ‘‘emerging signals.’’ For the purposes of this guidance, an emerging IV. Paperwork Reduction Act of 1995 the use of appropriate automated, signal is new information about a electronic, mechanical, or other This draft guidance refers to technological collection techniques or medical device used in clinical practice: previously approved collections of (1) That the Agency is monitoring or other forms of information technology. information found in FDA regulations. analyzing, (2) that has the potential to FOR FURTHER INFORMATION CONTACT: To These collections of information are impact patient management decisions obtain a copy of the data collection subject to review by the Office of and/or alter the known benefit-risk plans and instruments, submit Management and Budget (OMB) under profile of the device, (3) that has not yet comments in writing, or request more the Paperwork Reduction Act of 1995 been fully validated or confirmed, and information on the proposed project, (44 U.S.C. 3501–3520). The collections (4) for which the Agency does not yet contact: Paul Sorlie, 6701 Rockledge of information in 21 CFR parts 801 and have specific recommendations. Drive, MSC 7936, Bethesda, MD 20892, 808, regarding labelling, have been We believe there is a need to notify or call non-toll-free number (301) 435– approved under OMB control number the public about emerging signals that 0456, or Email your request to: sorliep@ 0910–0485 and the collections of the Agency is monitoring or analyzing, nhlbi.nih.gov. Formal requests for information in 21 CFR part 803, even when the information has not been additional plans and instruments must regarding medical device reporting, fully analyzed, validated, or confirmed, be requested in writing. have been approved under OMB control and for which the Agency does not yet Comments Due Date: Comments numbers 0910–0291, 0910–0437, and have specific recommendations. Timely regarding this information collection are 0910–0471. communication about emerging signals best assured of having their full effect if is intended to provide health care Dated: December 28, 2015. received within 60 days of the date of providers, patients, and consumers with Leslie Kux, this publication. access to the most current information Associate Commissioner for Policy. Proposed Collection: The Framingham concerning the potential benefits and [FR Doc. 2015–32920 Filed 12–30–15; 8:45 am] Heart Study, Revision, 0925–0216 risks of marketed devices, so that they BILLING CODE 4164–01–P Expiration Date: 10/31/2016, National can make informed treatment choices Heart, Lung, and Blood Institute bases on all available information. (NHLBI), the National Institutes of Therefore, because of the evolving DEPARTMENT OF HEALTH AND Health (NIH). nature of this information, FDA would HUMAN SERVICES Need and Use of Information be sharing it with the public at an early Collection: This proposal is to extend stage of the Agency’s assessment and National Institutes of Health the Framingham Study to examine the evaluation of the signal. Generation Three Cohort, New Offspring Proposed Collection; 60 Day Comment Spouses and Omni Group 2 Cohort, as II. Significance of Guidance Request; The Framingham Heart Study well as to continue to monitor the This draft guidance is being issued (NHLBI) morbidity and mortality which occurs consistent with FDA’s good guidance AGENCY: National Institutes of Health, in all Framingham Cohorts. The practices regulation (21 CFR 10.115). HHS. contractor, with the collaborative The draft guidance, when finalized, will ACTION: Notice. assistance of NHLBI Intramural staff, tkelley on DSK3SPTVN1PROD with NOTICES represent the current thinking of FDA will invite study participants, schedule on ‘‘Public Notification of Emerging SUMMARY: In compliance with the appointments, administer examinations Postmarket Medical Device Signals requirement of Section 3506(c)(2)(A) of and testing, enter information into (‘Emerging Signals’).’’ It does not the Paperwork Reduction Act of 1995, computer databases for editing, and establish any rights for any person and for opportunity for public comment on prepare scientific reports of the is not binding on FDA or the public. proposed data collection projects, the information for publication in You can use an alternative approach if National Heart, Lung, and Blood appropriate scientific journals. All VerDate Sep<11>2014 16:49 Dec 30, 2015 Jkt 238001 PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 E:\FR\FM\31DEN1.SGM 31DEN1

Federal Register / Vol. 80, No. 251 / Thursday, December 31, 2015 / Notices 81831 participants have been examined Institute uses the results of the effective treatment and preventive previously and thus the study deals Framingham Study to: (1) Characterize modalities can be developed and tested. with a stable, carefully described group. risk factors for cardiovascular and lung Most of the reports of study results have Data are collected in the form of an diseases so that national prevention been published in peer reviewed observational health examination programs can be designed and medical journals and books. involving such components as blood implemented; (2) evaluate trends in OMB approval is requested for 3 pressure measurements, venipuncture, cardiovascular diseases and risk factors years. There are no costs to respondents electrocardiography and a health over time to measure the impact of other than their time. The total interview, including questions about overall preventive measures; and (3) estimated annualized burden hours are lifestyles and daily living situations. understand the etiology of 8,382. The National Heart, Lung, and Blood cardiovascular and lung diseases so that Estimated Annualized Burden Hours TABLE A.12–1.1—ESTIMATE OF RESPONDENT BURDEN, ORIGINAL COHORT [Annualized] Number of Average time Number of Total annual Type of respondent responses per per response respondents burden hour respondent (in hours) I. PARTICIPANT COMPONENTS ANNUAL FOLLOW-UP a. Records Request .................................................................................. 30 1 15/60 8 b. Health Status Update ........................................................................... 30 1 15/60 8 SUB–TOTAL: PARTICIPANT COMPONENTS ................................. * 30 ........................ ........................ 15 II. NON-PARTICIPANT COMPONENTS A. Informant Contact (Pre-exam and Annual Follow-up) ......................... 15 1 10/60 3 B. Records Request (Annual follow-up) ................................................... 30 1 15/60 8 SUB-TOTAL: NON-PARTICIPANT COMPONENTS ........................ 45 ........................ ........................ 10 TOTAL: PARTICIPANT AND NON-PARTICIPANT COMPO- NENTS .................................................................................... 75 ........................ ........................ 25 * Number of participants as reflected in Row I.b. above. TABLE A.12–1.2—ESTIMATE OF RESPONDENT BURDEN, OFFSPRING COHORT AND OMNI GROUP 1 COHORT [Annualized] Number of Average time Number of Total annual Type of respondent responses per per response respondents respondent (in hours) burden hour I. PARTICIPANT COMPONENTS ANNUAL FOLLOW-UP a. Records Request .................................................................................. 1,500 1 15/60 375 b. Health Status Update ........................................................................... 1,700 1 15/60 425 SUB-TOTAL: PARTICIPANT COMPONENTS .................................. * 1,700 ........................ ........................ 800 II. NON-PARTICIPANT COMPONENTS A. Informant contact (Pre-exam and Annual Follow-up) .......................... 150 1 10/60 25 B. Records Request (Annual follow-up) ................................................... 1,500 1 15/60 375 SUB-TOTAL: NON-PARTICIPANT COMPONENTS ........................ 1,650 ........................ ........................ 400 TOTAL: PARTICIPANT AND NON-PARTICIPANT COMPO- NENTS .................................................................................... 3,350 ........................ ........................ 1,200 * Number of participants as reflected in Row I.b. above. TABLE A.12–1.3—ESTIMATE OF RESPONDENT BURDEN, GENERATION 3 COHORT, NOS AND OMNI GROUP 2 COHORT [Annualized] Average time Number of Number of per response Total annual Type of respondent responses per respondents (hours per burden hour respondent year) tkelley on DSK3SPTVN1PROD with NOTICES I. PARTICIPANT COMPONENTS A. PRE-EXAM: 1.Telephone contact for appointment ....................................................... 1,450 1 10/60 242 2. Exam appointment, scheduling, reminder and instructions ................. 1,270 1 35/60 741 B. EXAM CYCLE 3: 1. Exam at study center ........................................................................... 1,200 1 110/60 2,200 VerDate Sep<11>2014 16:49 Dec 30, 2015 Jkt 238001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\31DEN1.SGM 31DEN1

81832 Federal Register / Vol. 80, No. 251 / Thursday, December 31, 2015 / Notices TABLE A.12–1.3—ESTIMATE OF RESPONDENT BURDEN, GENERATION 3 COHORT, NOS AND OMNI GROUP 2 COHORT— Continued [Annualized] Average time Number of Number of per response Total annual Type of respondent responses per respondents (hours per burden hour respondent year) 2. Home or nursing home visit ................................................................. 35 1 60/60 35 C. POST-EXAM: eFHS Mobile Technology for Collection of CVD Risks ............................ 1,100 18 9/60 2,970 D. ANNUAL FOLLOW-UP: 1. Records Request .................................................................................. 1,200 1 15/60 300 2. Health Status Update ........................................................................... 1,400 1 15/60 350 Sub-Total: Participant Components .................................................. * 2,850 ........................ ........................ 6,830 II. NON-PARTICIPANT COMPONENTS—ANNUAL FOLLOW-UP A. INFORMANT CONTACTS .......................................................................... 180 1 10/60 30 B. RECORD REQUEST .................................................................................. 1,155 1 15/60 289 Sub-Total: Non-Participant Components .................................................. 1,335 ........................ ........................ 319 Total: Participant And Non-Participant Components ........................ 4,185 ........................ ........................ 7,157 * Number of participants as reflected in Rows I.A.1 and I.D.2 above. Dated: December 22, 2015. Place: Intramural Research Program, individuals associated with the grant Valery Gheen, National Institute on Drug Abuse, NIH, Johns applications, the disclosure of which NHLBI Project Clearance Liaison, National Hopkins Bayview Campus, Baltimore, MD would constitute a clearly unwarranted Institutes of Health. 21223. invasion of personal privacy. Contact Person: Joshua Kysiak, Program [FR Doc. 2015–32940 Filed 12–30–15; 8:45 am] Specialist, Biomedical Research Center, Name of Committee: National Institute on BILLING CODE 4140–01–P Intramural Research Program, National Drug Abuse Special Emphasis Panel; Tools Institute on Drug Abuse, NIH, DHHS, 251 for Monitoring and Manipulating RNA Bayview Boulevard, Baltimore, MD 21224, Modifications (R41, R42, R43, R44). DEPARTMENT OF HEALTH AND 443–740–2465, kysiakjo@nida.nih.gov. Date: February 18, 2016. HUMAN SERVICES (Catalogue of Federal Domestic Assistance Time: 9:00 a.m. to 4:00 p.m. Program Nos.: 93.279, Drug Abuse and Agenda: To review and evaluate grant National Institutes of Health Addiction Research Programs, National applications. Institutes of Health, HHS) Place: Hilton Garden Inn Bethesda, 7301 National Institute on Drug Abuse; Waverly Street, Bethesda, MD 20814. Dated: December 28, 2015. Contact Person: Jagadeesh S. Rao, Ph.D., Notice of Closed Meeting Natasha M. Copeland, Scientific Review Officer, Office of Program Analyst, Office of Federal Advisory Extramural Policy and Review, National Pursuant to section 10(d) of the Institute on Drug Abuse, National Institutes Federal Advisory Committee Act, as Committee Policy. of Health, DHHS, 6001 Executive Boulevard, amended (5 U.S.C. App.), notice is [FR Doc. 2015–32939 Filed 12–30–15; 8:45 am] Room 4234, MSC 9550, Bethesda, MD 02892, hereby given of a meeting of the Board BILLING CODE 4140–01–P 301–443–9511, jrao@nida.nih.gov. of Scientific Counselors, NIDA. (Catalogue of Federal Domestic Assistance The meeting will be closed to the Program Nos.: 93.279, Drug Abuse and DEPARTMENT OF HEALTH AND Addiction Research Programs, National public as indicated below in accordance HUMAN SERVICES Institutes of Health, HHS) with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended National Institutes of Health Dated: December 28, 2015. for the review, discussion, and Natasha M. Copeland, evaluation of individual intramural National Institute on Drug Abuse; Program Analyst, Office of Federal Advisory programs and projects conducted by the Notice of Closed Meeting Committee Policy. National Institute on Drug Abuse, [FR Doc. 2015–32937 Filed 12–30–15; 8:45 am] including consideration of personnel Pursuant to section 10(d) of the BILLING CODE 4140–01–P qualifications and performance, and the Federal Advisory Committee Act, as competence of individual investigators, amended (5 U.S.C. App), notice is the disclosure of which would hereby given of the following meeting. DEPARTMENT OF HEALTH AND constitute a clearly unwarranted The meeting will be closed to the HUMAN SERVICES invasion of personal privacy. public in accordance with the tkelley on DSK3SPTVN1PROD with NOTICES provisions set forth in sections National Institutes of Health Name of Committee: Board of Scientific 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Counselors, NIDA. Date: February 1–2, 2016. as amended. The grant applications and National Institute of Allergy and Closed: 8:30 a.m. to 5:00 p.m. the discussions could disclose Infectious Diseases; Closed Meeting Agenda: To review and evaluate personal confidential trade secrets or commercial qualifications and performance, and property such as patentable materials, Pursuant to section 10(d) of the competence of individual investigators. and personal information concerning Federal Advisory Committee Act, as VerDate Sep<11>2014 16:49 Dec 30, 2015 Jkt 238001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\31DEN1.SGM 31DEN1


Document Created: 2015-12-31 02:14:44
Document Modified: 2015-12-31 02:14:44
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesComments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication.
ContactTo obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Paul Sorlie, 6701 Rockledge Drive, MSC 7936, Bethesda, MD 20892, or call non-toll- free number (301) 435-0456, or Email your request to: [email protected] Formal requests for additional plans and instruments must be requested in writing.
FR Citation80 FR 81830 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR